EN
HI
Brawn Biotech Share Price
220.00 (0.00%)
Last updated on 5 Sep, 2026 | 16:00 IST
Free Demat with Zero AMC*
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
Summary
As of 14 Nov, 2026, Brawn Biotech stock price is ₹22. During the trading session, the stock has moved between an intraday low of ₹0.00 and an intraday high of ₹0.00. Over the last 52 weeks, Brawn Biotech has traded between ₹17.71 and ₹24.37.
The stock has recorded a trading volume of 0 shares,. Its Average Traded Price (ATP) is ₹0.00, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 0 @ ₹22.00.
Brawn Biotech has an upper circuit limit of ₹23.10 and a lower circuit limit of ₹20.90. The total value traded stands at ₹0.00, and the delivery percentage for the day is 0%.
The stock is currently traded with a market lot size of 1. Brawn Biotech also offers a dividend yield of 0%.
Brawn Biotech Share Price Chart
Brawn Biotech Share Key Metrics
Volume
0.00
Market Cap
6.81 CR
LTQ@LTP
0@22.00
ATP
0
Var Margin
25.18 %
Circuit Range
20.9-23.1
Delivery %
0 %
Value
0.00
ASM/GSM
No
Market Lot
1
Brawn Biotech Resistance and Support
Pivot 22
Resistance
First Resistance
22
Second Resistance
22
Third Resistance
22
Support
First Support
22
Second Support
22
Third Support
22
Brawn Biotech Shareholding Pattern
View More- 2016-17
- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
52.94%
Mutual Fund
0.35%
Insurance
0%
Foreign Institutional Investors
0%
Domestic Institutional Investors
0%
Retail
46.71%
Others
0%
Total Promoters
MAR '26
52.94%
JUN '26
52.94%
SEP '26
52.94%
Brawn Biotech Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-05 | Quarterly Results |
| 2026-08-13 | Quarterly Results |
| 2026-05-29 | Audited Results |
| 2025-11-14 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-26 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-14 | Quarterly Results |
| 2024-08-14 | Quarterly Results |
Brawn Biotech News
Brawn Biotech Ltd - 530207 - Board Meeting Outcome for Outcome Of Board Meeting Held On 5Th November, 2026 To Consider And Approve, Inter-Alia, Un-Audited Financial Results Of The Company For Quarter Ended September 30, 2026.
Brawn Biotech reported Q2 FY27 revenue of ₹5.76 crores, reflecting an increase of 15.7% YoY, and a net profit of ₹0.03 crores, down 57.5% YoY. Total expenses for the quarter were ₹5.73 crores.
Nov 05 2026 14:31:55
Brawn Biotech Ltd - 530207 - Board Meeting Intimation for Consideration And Approval Of, Inter Alia, The Un-Audited Financial Results Of The Company For The Quarter Ended September 30, 2026.
Brawn Biotech announced a board meeting scheduled for November 5, 2026. The board will approve the financial results for the quarter ended September 30, 2026.
Oct 29 2026 15:20:15
Brawn Biotech Management
| Name | Position |
|---|---|
| Mayank Jain | Non Executive Independent Director |
| Pooja Jha | Non Executive Independent Director |
Brawn Biotech Similar Stocks
Gratex Industries Ltd.
16.63
0.00 (0.00%)
Nyssa Corporation Ltd.
1.97
0.00 (0.00%)
Sunraj Diamond Exports Ltd.
11.31
0.00 (0.00%)
Artemis ADR Marketplace Ltd.
0.00
0.00 (0.00%)
Vivanza Biosciences Ltd.
1.48
0.00 (0.00%)
Lexoraa Industries Ltd.
14.80
0.00 (0.00%)
Amanaya Ventures Ltd.
18.90
0.00 (0.00%)
Munoth Communication Ltd.
5.96
0.00 (0.00%)
Standard Shoe Sole & Mould (India) Ltd.
11.05
0.00 (0.00%)
Brawn Biotech FAQs
The Buying Price of Brawn Biotech share is 22 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Brawn Biotech stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Brawn Biotech, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Brawn Biotech shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Brawn Biotech shares is 0. Useful to assess the stock's value relative to its book value.
To assess Brawn Biotech’s valuation compare Sector P/E, P/B which are 47.36 & 1.71 with sector averages, along with growth rates and financial metrics.
The Market Cap of Brawn Biotech is 6.81 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Brawn Biotech share price is 24.37 & 17.71. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Brawn Biotech belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Open Your Free
Demat Account Now!
AMC For First Year
Account Opening Fee
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools
Invest in BRAWN
Account Opening Fee AMC for 1st Year Auto Square Off Charges Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC